BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23295774)

  • 21. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
    Lim SB; Choi HS; Jeong SY; Kim DY; Jung KH; Hong YS; Chang HJ; Park JG
    Ann Surg; 2008 Aug; 248(2):243-51. PubMed ID: 18650634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncologic outcomes of pathologic stage I lower rectal cancer with or without preoperative chemoradiotherapy: are they comparable?
    Huh JW; Kim CH; Kim HR; Kim YJ
    Surgery; 2011 Nov; 150(5):980-4. PubMed ID: 21875732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complications after sphincter-saving resection in rectal cancer patients according to whether chemoradiotherapy is performed before or after surgery.
    Kim CW; Kim JH; Yu CS; Shin US; Park JS; Jung KY; Kim TW; Yoon SN; Lim SB; Kim JC
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):156-63. PubMed ID: 20106604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term clinical and functional results of intersphincteric resection for lower rectal cancer.
    Koyama M; Murata A; Sakamoto Y; Morohashi H; Takahashi S; Yoshida E; Hakamada K
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S422-8. PubMed ID: 24562938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors for low rectal cancer patients undergoing intersphincteric resection after neoadjuvant chemoradiation.
    Lee SY; Jo JS; Kim HJ; Kim CH; Kim YJ; Kim HR
    J Surg Oncol; 2015 Jun; 111(8):1054-8. PubMed ID: 25977149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laparoscopic versus open intersphincteric resection and coloanal anastomosis for low rectal cancer: intermediate-term oncologic outcomes.
    Park JS; Choi GS; Jun SH; Hasegawa S; Sakai Y
    Ann Surg; 2011 Dec; 254(6):941-6. PubMed ID: 22076066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sphincter preservation in low rectal cancer is facilitated by preoperative chemoradiation and intersphincteric dissection.
    Weiser MR; Quah HM; Shia J; Guillem JG; Paty PB; Temple LK; Goodman KA; Minsky BD; Wong WD
    Ann Surg; 2009 Feb; 249(2):236-42. PubMed ID: 19212176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of smooth muscle plasty after intersphincteric rectal resection to replace a partially resected internal anal sphincter: long-term follow-up.
    Krand O; Yalti T; Tellioglu G; Kara M; Berber I; Titiz MI
    Dis Colon Rectum; 2009 Nov; 52(11):1895-901. PubMed ID: 19966639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient-centered outcomes to decide treatment strategy for patients with low rectal cancer.
    Honda M; Akiyoshi T; Noma H; Ogura A; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M
    J Surg Oncol; 2016 Oct; 114(5):630-636. PubMed ID: 27761895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early results of intersphincteric resection for patients with very low rectal cancer: an active approach to avoid a permanent colostomy.
    Saito N; Ono M; Sugito M; Ito M; Morihiro M; Kosugi C; Sato K; Kotaka M; Nomura S; Arai M; Kobatake T
    Dis Colon Rectum; 2004 Apr; 47(4):459-66. PubMed ID: 14978613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anal function after endoluminal locoregional resection by transanal endoscopic microsurgery and radiotherapy for rectal cancer.
    Biviano I; Balla A; Badiali D; Quaresima S; D'Ambrosio G; Lezoche E; Corazziari E; Paganini AM
    Colorectal Dis; 2017 Jun; 19(6):O177-O185. PubMed ID: 28304143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.
    Shanmugan S; Arrangoiz R; Nitzkorski JR; Yu JQ; Li T; Cooper H; Konski A; Farma JM; Sigurdson ER
    Ann Surg Oncol; 2012 Jul; 19(7):2178-85. PubMed ID: 22395978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-Term Functional Outcomes of Total Mesorectal Excision Following Chemoradiotherapy for Lower Rectal Cancer: Stapled Anastomosis versus Intersphincteric Resection.
    Beppu N; Kimura H; Matsubara N; Tomita N; Yanagi H; Yamanaka N
    Dig Surg; 2016; 33(1):33-42. PubMed ID: 26569467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between pathologic features of peripheral nerves and postoperative anal function after neoadjuvant therapy for low rectal cancer.
    Koushi K; Nishizawa Y; Kojima M; Fujii S; Saito N; Hayashi R; Ochiai A; Ito M
    Int J Colorectal Dis; 2016 Dec; 31(12):1845-1852. PubMed ID: 27655392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intersphincteric resection for low rectal cancer: laparoscopic vs open surgery approach.
    Laurent C; Paumet T; Leblanc F; Denost Q; Rullier E
    Colorectal Dis; 2012 Jan; 14(1):35-41; discussion 42-3. PubMed ID: 21114752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intersphincteric resection for very low rectal adenocarcinoma: univariate and multivariate analyses of risk factors for recurrence.
    Akasu T; Takawa M; Yamamoto S; Ishiguro S; Yamaguchi T; Fujita S; Moriya Y; Nakanishi Y
    Ann Surg Oncol; 2008 Oct; 15(10):2668-76. PubMed ID: 18618181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer.
    Luna-Pérez P; Reyna Huelga A; Labastida Almendaro S; Rodríguez-Coria DF; González Macouzet J; Delgado Gallardo S
    Rev Invest Clin; 1999; 51(4):205-13. PubMed ID: 10546501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].
    Mátrai Z; Lövey J; Hitre E; Orosz Z; Gödény M; Péley G; Sulyok Z; Rényi Vámos F; Farkas E; Köves I
    Orv Hetil; 2006 Oct; 147(42):2011-20. PubMed ID: 17165600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Partial longitudinal resection of the anorectum and sphincter for very low rectal adenocarcinoma: a surgical approach to avoid permanent colostomy.
    Cong JC; Chen CS; Zhang H; Qiao L; Liu EQ
    Colorectal Dis; 2012 Jun; 14(6):697-704. PubMed ID: 21689354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of interval between neoadjuvant chemoradiotherapy and TME for locally advanced rectal cancer on pathologic response and oncologic outcome.
    Wolthuis AM; Penninckx F; Haustermans K; De Hertogh G; Fieuws S; Van Cutsem E; D'Hoore A
    Ann Surg Oncol; 2012 Sep; 19(9):2833-41. PubMed ID: 22451236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.